U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. International Programs
  3. International Arrangements
  4. Cooperative Arrangements
  5. Confidentiality Commitments
  6. INAB Ireland - FDA, Confidentiality Commitment
  1. Confidentiality Commitments

INAB Ireland - FDA, Confidentiality Commitment

CONFIDENTIALITY COMMITMENT STATEMENT OF LEGAL AUTHORITY AND COMMITMENT FROM THE IRISH NATIONAL ACCREDITATION BOARD NOT TO PUBLICLY DISCLOSE NON-PUBLIC INFORMATION SHARED BY THE U. S. FOOD AND DRUG ADMINISTRATION (USFDA), U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

The United States Food and Drug Administration (USFDA), a part of the United States Department of Health and Human Services, is authorized under 21 C.F.R. § 20.89 ("Communications with Foreign Government Officials") to disclose non-public information to The Irish National Accreditation Board (INAB) regarding USFDA regulated products as part of cooperative law enforcement or cooperative regulatory activities. This sharing is in the interest of public health as it relates to the monitoring of non clinical laboratories and nonclinical laboratory studies.

The INAB understands that some of the information it receives from USFDA may include non-public information exempt from public disclosure under the laws and regulations of the United States of America, such as confidential commercial information; trade secret information; personal privacy information; law enforcement information; or internal, pre- decisional information. The INAB understands that this non-public information is shared in confidence, and that USFDA considers it critical that the INAB maintain the confidentiality of the information. Public disclosure of this information by the INAB could seriously jeopardize any further scientific and regulatory interactions between USFDA and the INAB. US FDA will advise the INAB of the non-public status of the information at the time that the information is shared.

Therefore, the INAB certifies that it:

has the authority to protect the non-public information provided to the INAB in confidence by the USFDA from public disclosure; will not publicly disclose the US FDA-provided non-public information without the written authorization of the owner of the information, the written authorization from the individual who is the subject of the personal privacy information, or a written statement from USFDA that the information no longer has non-public status; will inform USFDA within two working days of any effort made to obtain US FDA- provided non-public information from the INAB by judicial or legislative mandate. If such judicial or legislative mandate orders disclosure of USFDA-provided non- public information, the INAB will take all measures in an effort to ensure that the information will be disclosed in a manner that protects the information from public disclosure; and will promptly inform USFDA of any changes to Irish laws, the INAB policies or procedures that would affect the INAB ability to honor the agreements in this document.

___________/s/___________ 
Signature of the INAB official

Tom Dempsey
__________________________
Print or type name of the INAB

Manager
_______________________
Title of the INAB official

The Irish National Accreditation Board
Wilton Park House
Wilton Place
Dublin 2
Ireland

Telephone and facsimile:
+353-1-6073181 tel
+353-1-6073109 fax
 

Date: 14 June 2005

Back to Top